The PPARγ agonist pioglitazone ameliorates aging-related progressive renal injury

Journal of the American Society of Nephrology

Volumn 20, Issue 11, 2009, Pages 2380-2388

  Yang, Hai Chun ^a,b   Deleuze, Sebastien ^a   Zuo, Yiqin ^a   Potthoff, Sebastian A ^a,c   Ma, Li Jun ^a   Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b FUDAN UNIVERSITY   (China)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; KLOTHO PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN KINASE C BETA; PROTEIN P66; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; 2,4 THIAZOLIDINEDIONE DERIVATIVE;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGING; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; RAT; RENAL PROTECTION; AGE; ANIMAL; DISEASE COURSE; DRUG POTENTIATION; KIDNEY DISEASE; SPRAGUE DAWLEY RAT;

AGE FACTORS; AGING; ANIMALS; DISEASE PROGRESSION; KIDNEY DISEASES; MALE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES;

EID: 72049124334     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008111138     Document Type: Article

References (44)

1. Beck LH: Changes in renal function with aging. Clin Geriatr Med 14: 199-209, 1998
2. McLachlan M, Wasserman P: Changes in sizes and distensibility of the aging kidney. Br J Radiol 54: 488-491, 1981 (Pubitemid 11122966)
3. Fuiano G, Sund S, Mazza G, Rosa M, Caglioti A, Gallo G, Natale G, Andreucci M, Memoli B, De Nicola L, Conte G: Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 59: 1052-1058, 2001 (Pubitemid 32206867)
4. Melk A, Halloran PF: Cell senescence and its implications for nephrology. J Am Soc Nephrol 12: 385-393, 2001 (Pubitemid 32116383)
5. McLean AJ, Le Couteur DG: Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56: 163-184, 2004
6. Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T: Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Arzneimittelforschung 40: 263-267, 1990 (Pubitemid 20103604)
7. Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB: Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 59: 1899-1910, 2001
8. Yang HC, Ma LJ, Ma J, Fogo AB: Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. Kidney Int 69: 1756-1764, 2006 (Pubitemid 43739202)
9. Gumieniczek A: Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits. Life Sci 74: 553-562, 2003
10. Ghosh S, Patel N, Rahn D, McAllister J, Sadeghi S, Horwitz G, Berry D, Wang KX, Swerdlow RH: The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells. Mol Pharmacol 71: 1695-1702, 2007 (Pubitemid 47010922)
11. Barbieri M, Bonafe M, Rizzo MR, Ragno E, Olivieri F, Marchegiani F, Franceschi C, Paolisso G: Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)gamma-2 with longevity. Exp Gerontol 39: 1095-1100, 2004 (Pubitemid 38952890)
12. Sung B, Park S, Yu BP, Chung HY: Modulation of PPAR in aging, inflammation, and calorie restriction. J Gerontol A Biol Sci Med Sci 59: 997-1006, 2004 (Pubitemid 39441788)
13. Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB: Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 58: 2425-2436, 2000
14. Kujoth GC, Bradshaw PC, Haroon S, Prolla TA: The role of mitochondrial DNA mutations in mammalian aging. PLoS Genet 3: e24, 2007
15. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, Prolla TA: Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481-484, 2005 (Pubitemid 40994689)
16. Verrier E, Wang L, Wadham C, Albanese N, Hahn C, Gamble JR, Chatterjee VK, Vadas MA, Xia P: PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: Role of diacylglycerol kinase. Circ Res 94: 1515-1522, 2004 (Pubitemid 38780325)
17. Hajnoczky G, Hoek JB: Cell signaling. Mitochondrial longevity pathways. Science 315: 607-609, 2007 (Pubitemid 46214696)
18. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003 (Pubitemid 36043346)
19. Hotta K, Bodkin NL, Gustafson TA, Yoshioka S, Ortmeyer HK, Hansen BC: Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. J Gerontol A Biol Sci Med Sci 54: B183-B188, 1999 (Pubitemid 29252701)
20. Ye P, Zhang XJ, Wang ZJ, Zhang C: Effect of aging on the expression of peroxisome proliferator-activated receptor gamma and the possible relation to insulin resistance. Gerontology 52: 69-75, 2006 (Pubitemid 43325985)
21. Knight JA: The biochemistry of aging. Adv Clin Chem 35: 1-62, 2000
22. Guo B, Koya D, Isono M, Sugimoto T, Kashiwagi A, Haneda M: Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells. Diabetes 53: 200-208, 2004 (Pubitemid 38044716)
23. Girnun GD, Domann FE, Moore SA, Robbins ME: Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 16: 2793-2801, 2002 (Pubitemid 36020658)
24. Zhang H, Li Y, Fan Y, Wu J, Zhao B, Guan Y, Chien S, Wang N: Klotho is a target gene of PPAR-gamma. Kidney Int 74: 732-739, 2008
25. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90: 7915-7922, 1993 (Pubitemid 23260825)
26. Cadet J, Douki T, Ravanat JL: Artifacts associated with the measurement of oxidized DNA bases. Environ Health Perspect 105: 1034-1039, 1997 (Pubitemid 28134980)
27. Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, Gavrilyuk V, Dello Russo C: Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem Pharmacol 70: 177-188, 2005 (Pubitemid 40814400)
28. Turturro F, Oliver R, 3rd, Friday E, Nissim I, Welbourne T: Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines. Am J Physiol Cell Physiol 292: C1137-C1146, 2007 (Pubitemid 46440401)
29. Scarpulla RC: Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 286: 81-89, 2002
30. Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, Prins JB: Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes 47: 138-141, 1998 (Pubitemid 28030822)
31. Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Moller DE: Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression Endocrinology 139: 4920-4927, 1998 (Pubitemid 28533438)
32. Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, Hart CM: Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288: C899-905, 2005 (Pubitemid 40395068)
33. Mahgoub MA, Abd-Elfattah AS: Diabetes mellitus and cardiac function. Mol Cell Biochem 180: 59-64, 1998
34. Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, Katayama S: The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50: 3-11, 2001 (Pubitemid 32058541)
35. Camougrand N, Rigoulet M: Aging and oxidative stress: Studies of some genes involved both in aging and in response to oxidative stress. Respir Physiol 128: 393-401, 2001 (Pubitemid 33051011)
36. Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233, 2005
37. Shc regulates mitochondrial metabolism. J Biol Chem 281: 10555-10560, 2006
38. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C, Minucci S, Mantovani F, Wieckowski MR, Del Sal G, Pelicci PG, Rizzuto R: Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 315: 659-663, 2007 (Pubitemid 46214712)
39. Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, Sugawara A, Yagihashi S: Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma- ligand, in insulin-deficient diabetic rats. J Neurochem 104: 491-499, 2008 (Pubitemid 350293884)
40. Ceolotto G, Gallo A, Papparella I, Franco L, Murphy E, Iori E, Pagnin E, Fadini GP, Albiero M, Semplicini A, Avogaro A: Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol 27: 2627-2633, 2007 (Pubitemid 350158915)
41. Sasaki M, Jordan P, Welbourne T, Minagar A, Joh T, Itoh M, Elrod JW, Alexander JS: Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha. BMC Physiol 5: 3, 2005 (Pubitemid 40390000)
42. Liu HB, Hu YS, Medcalf RL, Simpson RW, Dear AE: Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation. Biochem Biophys Res Commun 334: 30-37, 2005
43. Takaki A, Jimi S, Segawa M, Iwasaki H: Cadmium-induced nephropathy in rats is mediated by expression of senescence-associated beta-galactosidase and accumulation of mitochondrial DNA deletion. Ann N Y Acad Sci 1011: 332-338, 2004 (Pubitemid 38608418)
44. Filser N, Margue C, Richter C: Quantification of wild-type mitochondrial DNA and its 4.8-kb deletion in rat organs. Biochem Biophys Res Commun 233: 102-107, 1997 (Pubitemid 27215917)